Atea Pharmaceuticals, Inc. (AVIR) has 14 open-market insider trades by 9 insiders since 2020. Over the last six months insiders net bought $25K. The most active filer is Franklin M. Berger, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Andrew A. F. Hack | Dir | — | 1 | $6.0M | 2020-11-03 |
| Rock Springs Capital Master Fund LP | 10% Owner | — | 1 | $6.0M | 2020-11-03 |
| Franklin M. Berger | Dir | — | 4 | $3.4M | 2026-06-18 |
| Polly A. Murphy | Dir | — | 3 | $154K | 2026-06-18 |
| Bruce Polsky | Dir | — | 1 | $122K | 2026-06-18 |
| Maria Arantxa Horga | — | — | 1 | $61K | 2026-01-31 |
| Andrea Corcoran | — | — | 1 | $61K | 2026-03-11 |
| Janet Mj Hammond | — | — | 1 | $54K | 2026-01-31 |
| Jean-Pierre Sommadossi | CEOChairmanPres | — | 1 | $4K | 2026-02-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Polly A. Murphy | Director | Buy | $25K | 2026-05-18 |
| Polly A. Murphy | Director | Buy | $25K | 2025-05-18 |
| Franklin M. Berger | Director | Buy | $81K | 2025-01-15 |
| Franklin M. Berger | Director | Sell | $2.0M | 2024-12-10 |
| Jean-Pierre Sommadossi | CEO & Chairman +1 | Sell | $461K | 2024-09-17 |
| Bruce Polsky | Director | Sell | $122K |
Companies that share insiders with AVIR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-06-20 |
| Jean-Pierre Sommadossi | CEO & Chairman +1 | Sell | $4K | 2024-06-05 |
| John Vavricka | Chief Commercial Officer | Sell | $45K | 2024-02-01 |
| Andrea Corcoran | — | Sell | $122K | 2024-02-01 |
| Jean-Pierre Sommadossi | CEO & Chairman +1 | Sell | $438K | 2024-02-01 |
| Maria Arantxa Horga | — | Sell | $122K | 2024-02-01 |
| Janet Mj Hammond | — | Sell | $108K | 2024-02-01 |
| Wayne Foster | EVP & Chief Accounting Officer | Sell | $48K | 2024-02-01 |
| Franklin M. Berger | Director | Sell | $298K | 2022-11-11 |
| Polly A. Murphy | Director | Buy | $103K | 2021-12-20 |